Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.
from MobiHealthNews https://ift.tt/2ImVIgF
April 02, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Ascensia Diabetes launches upgraded version of app in the USThis morning Ascensia Diabetes Care launched the latest version of its Contour Diabetes app in the United States. The upgraded app will offer users a new feature, called My Patterns, which will give personalized feedbac… Read More
Healthcare investor 7wiresVentures closes $100M for startup fund, forms coalitionAs technology increases in the healthcare arena more and more venture firms are turning their attention to digital health. from MobiHealthNews https://ift.tt/2I9s0fo … Read More
Kessler Foundation, Virtualware team up to create VR tool for stroke patientsPatients often have a long and difficult road to recovery following a stroke, but now developers are turning to virtual reality to assist in their therapy. Rehabilitation research group the Kessler Foundation and … Read More
Appointment booking app Solv announces $16.8M funding round, launch of new payments productSan Francisco-based appointment booking app Solv Health announced today that it has closed a $16.8 million Series B round of funding. The round was led by Greylock Partners, with participation from Benchmark and Aspect Ventur… Read More
iRhythm lauds growing revenue, sales force expansion during Q1 2018 earnings calliRhythm Technologies, maker of the Zio XT and Zio AT adhesive heart monitors, announced first quarter financials boasting higher revenue and an improved gross margin during an earnings call for investors earlier this week. f… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment